By John Stanford The Federal Trade Commission just announced plans to “take an aggressive approach to tackling anticompetitive pharmaceutical mergers.” Kelly Slaughter, the acting head of … [Read more...]
EXCEPT WHERE INDICATED, THE OPINIONS EXPRESSED ON THIS PAGE ARE NOT NECESSARILY THOSE OF THE MILWAUKEE COURIER
Private Sector Investment Fuels Drug Development
By Nina Nguyen The FDA just approved a groundbreaking new treatment for cystic fibrosis, a disease that causes a life-threatening buildup of mucus in the lungs. This drug offers hope to the … [Read more...]